RxDoctor Payments Data

Jack Ayoub, MD

Obstetrics & Gynecology · Leesburg, VANPI 1790836690

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $219,355 of the $279,165 with a category attached, or 78.6%. AbbVie accounts for 85.8% of it on its own, with 33 other manufacturers making up the rest. Reporting peaked in 2019 at $171,861 and has fallen 99.7% since, to $582 in 2025. Among obstetrics & gynecology clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$279,165in general payments, 2019–2025

Across 618 payments — averaging $451.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$239K
  • Pfizer$29K
  • Therapeuticsmd, Inc.$5K
  • Myovant Sciences Inc.$2K
  • Sumitomo Pharma America, Inc.$686
  • Renovia Inc$648
  • plus $3K from 28 others
$7,000in research payments, 2019–2025

Across 1 payment — averaging $7000.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$7K

What the payments were for

  • Consulting fees$12,7505%
  • Speaking & faculty fees$219,35579%
  • Travel & lodging$36,14813%
  • Food & beverage$10,3174%
  • Education$720%
  • Gifts$5230%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$279,165 in reported general payments places this provider in the 95th percentile of 992 obstetrics & gynecology providers in Virginia.

See all obstetrics & gynecology providers in Virginia

Medicare billing

Part B allowed, 2024
$8,667
Medicare patients
15
Services billed
71

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other obstetrics & gynecology in Leesburg

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →